209 related articles for article (PubMed ID: 27364102)
1. LRRK2 interferes with aggresome formation for autophagic clearance.
Bang Y; Kim KS; Seol W; Choi HJ
Mol Cell Neurosci; 2016 Sep; 75():71-80. PubMed ID: 27364102
[TBL] [Abstract][Full Text] [Related]
2. Interplay between Leucine-Rich Repeat Kinase 2 (LRRK2) and p62/SQSTM-1 in Selective Autophagy.
Park S; Han S; Choi I; Kim B; Park SP; Joe EH; Suh YH
PLoS One; 2016; 11(9):e0163029. PubMed ID: 27631370
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein.
Ho DH; Seol W; Son I
Cell Cycle; 2019 Feb; 18(4):467-475. PubMed ID: 30712480
[TBL] [Abstract][Full Text] [Related]
4. Preconditioning stimulus of proteasome inhibitor enhances aggresome formation and autophagy in differentiated SH-SY5Y cells.
Bang Y; Kang BY; Choi HJ
Neurosci Lett; 2014 Apr; 566():263-8. PubMed ID: 24602982
[TBL] [Abstract][Full Text] [Related]
5. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.
Plowey ED; Cherra SJ; Liu YJ; Chu CT
J Neurochem; 2008 May; 105(3):1048-56. PubMed ID: 18182054
[TBL] [Abstract][Full Text] [Related]
6. LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase.
Ho DH; Kim H; Nam D; Sim H; Kim J; Kim HG; Son I; Seol W
Cell Biochem Funct; 2018 Dec; 36(8):431-442. PubMed ID: 30411383
[TBL] [Abstract][Full Text] [Related]
7. Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo.
Albanese F; Mercatelli D; Finetti L; Lamonaca G; Pizzi S; Shimshek DR; Bernacchia G; Morari M
Neurobiol Dis; 2021 Nov; 159():105487. PubMed ID: 34419621
[TBL] [Abstract][Full Text] [Related]
8. Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy body pathology.
Mamais A; Manzoni C; Nazish I; Arber C; Sonustun B; Wray S; Warner TT; Cookson MR; Lewis PA; Bandopadhyay R
Brain Res; 2018 Dec; 1701():75-84. PubMed ID: 30055128
[TBL] [Abstract][Full Text] [Related]
9. P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity.
Kalogeropulou AF; Zhao J; Bolliger MF; Memou A; Narasimha S; Molitor TP; Wilson WH; Rideout HJ; Nichols RJ
Biochem J; 2018 Apr; 475(7):1271-1293. PubMed ID: 29519959
[TBL] [Abstract][Full Text] [Related]
10. LRRK2 Promotes Tau Accumulation, Aggregation and Release.
Guerreiro PS; Gerhardt E; Lopes da Fonseca T; Bähr M; Outeiro TF; Eckermann K
Mol Neurobiol; 2016 Jul; 53(5):3124-3135. PubMed ID: 26014385
[TBL] [Abstract][Full Text] [Related]
11. GTP-binding inhibitors increase LRRK2-linked ubiquitination and Lewy body-like inclusions.
Thomas JM; Wang X; Guo G; Li T; Dai B; Nucifora LG; Nucifora FC; Liu Z; Xue F; Liu C; Ross CA; Smith WW
J Cell Physiol; 2020 Oct; 235(10):7309-7320. PubMed ID: 32180220
[TBL] [Abstract][Full Text] [Related]
12. Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2
Juárez-Flores DL; González-Casacuberta I; Ezquerra M; Bañó M; Carmona-Pontaque F; Catalán-García M; Guitart-Mampel M; Rivero JJ; Tobias E; Milisenda JC; Tolosa E; Marti MJ; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
J Transl Med; 2018 Jun; 16(1):160. PubMed ID: 29884186
[TBL] [Abstract][Full Text] [Related]
13. p62 (SQSTM1) and cyclic AMP phosphodiesterase-4A4 (PDE4A4) locate to a novel, reversible protein aggregate with links to autophagy and proteasome degradation pathways.
Christian F; Anthony DF; Vadrevu S; Riddell T; Day JP; McLeod R; Adams DR; Baillie GS; Houslay MD
Cell Signal; 2010 Oct; 22(10):1576-96. PubMed ID: 20600853
[TBL] [Abstract][Full Text] [Related]
14. N-Acyldopamine induces aggresome formation without proteasome inhibition and enhances protein aggregation via p62/SQSTM1 expression.
Matsumoto G; Inobe T; Amano T; Murai K; Nukina N; Mori N
Sci Rep; 2018 Jun; 8(1):9585. PubMed ID: 29941919
[TBL] [Abstract][Full Text] [Related]
15. ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression.
Zhu Y; Wang C; Yu M; Cui J; Liu L; Xu Z
Protein Cell; 2013 Sep; 4(9):711-21. PubMed ID: 27023913
[TBL] [Abstract][Full Text] [Related]
16. The Parkinson's disease protein LRRK2 impairs proteasome substrate clearance without affecting proteasome catalytic activity.
Lichtenberg M; Mansilla A; Zecchini VR; Fleming A; Rubinsztein DC
Cell Death Dis; 2011 Aug; 2(8):e196. PubMed ID: 21866175
[TBL] [Abstract][Full Text] [Related]
17. Cytosolic PINK1 promotes the targeting of ubiquitinated proteins to the aggresome-autophagy pathway during proteasomal stress.
Gao J; Li M; Qin S; Zhang T; Jiang S; Hu Y; Deng Y; Zhang C; You D; Li H; Mu D; Zhang Z; Jiang C
Autophagy; 2016; 12(4):632-47. PubMed ID: 27050454
[TBL] [Abstract][Full Text] [Related]
18. Fbxl18 targets LRRK2 for proteasomal degradation and attenuates cell toxicity.
Ding X; Barodia SK; Ma L; Goldberg MS
Neurobiol Dis; 2017 Feb; 98():122-136. PubMed ID: 27890708
[TBL] [Abstract][Full Text] [Related]
19. Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation.
Matikainen-Ankney BA; Kezunovic N; Mesias RE; Tian Y; Williams FM; Huntley GW; Benson DL
J Neurosci; 2016 Jul; 36(27):7128-41. PubMed ID: 27383589
[TBL] [Abstract][Full Text] [Related]
20. Leucine-rich repeat kinase 2 expression leads to aggresome formation that is not associated with alpha-synuclein inclusions.
Waxman EA; Covy JP; Bukh I; Li X; Dawson TM; Giasson BI
J Neuropathol Exp Neurol; 2009 Jul; 68(7):785-96. PubMed ID: 19535993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
